JP Morgan Chase
LBMH

JP Morgan Chase’s LIBERATOR MED HLDGS INC (NY) LBMH Stock Holding History

JP Morgan Chase’s Portfolio LBMH Stock Details LBMH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-18,342
Closed -$72K – 3717
2014
Q1 		$72K Buy
+18,342
New +$80.4K ﹤0.01% 3504

Other funds holding LBMH

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TA
Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
HCS
Harvest Capital Strategies San Francisco, California $73.7M AUM 7.47% 1-Year Est. Return

JP Morgan Chase's LBMH Position: Q2 2014 in Review

JP Morgan Chase sold out of LIBERATOR MED HLDGS INC (NY) (LBMH) in Q2 2014, closing a stake of 18,342 shares — an estimated $72K sold.

JP Morgan Chase first reported a position in LBMH in Q1 2014 and held it in 1 quarter. The position peaked at $72K in Q1 2014. 64 funds tracked by Wall St. Rank hold LBMH as of Q2 2014.

  • JP Morgan Chase reported no remaining LIBERATOR MED HLDGS INC (NY) position as of Q2 2014 after selling out during the quarter.
  • JP Morgan Chase sold 18,342 LIBERATOR MED HLDGS INC (NY) shares in Q2 2014, an estimated $72K.
  • JP Morgan Chase first reported a position in LIBERATOR MED HLDGS INC (NY) in Q1 2014 and held it in 1 quarter.
  • JP Morgan Chase's LIBERATOR MED HLDGS INC (NY) position peaked at $72K in Q1 2014.
  • 64 funds tracked by Wall St. Rank held LIBERATOR MED HLDGS INC (NY) as of Q2 2014.

Based on JP Morgan Chase's 13F filing for Q2 2014, filed 14 Aug 2014.